{"id":"https://openalex.org/W4411299435","doi":"https://doi.org/10.1016/j.ebiom.2025.105809","title":"Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial","display_name":"Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial","publication_year":2025,"publication_date":"2025-06-14","ids":{"openalex":"https://openalex.org/W4411299435","doi":"https://doi.org/10.1016/j.ebiom.2025.105809","pmid":"https://pubmed.ncbi.nlm.nih.gov/40517603","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12278623"},"language":"en","primary_location":{"id":"doi:10.1016/j.ebiom.2025.105809","doi":"https://doi.org/10.1016/j.ebiom.2025.105809","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ebiom.2025.105809","pdf_url":"https://www.thelancet.com/action/showPdf?pii=S2352396425002531","source":{"id":"https://openalex.org/S2531685872","display_name":"EBioMedicine","issn_l":"2352-3964","issn":["2352-3964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"eBioMedicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.thelancet.com/action/showPdf?pii=S2352396425002531","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077878781","display_name":"Nina Hertoghs","orcid":"https://orcid.org/0000-0002-9294-6586","observed_orcids":["https://orcid.org/0000-0002-9294-6586"]},"institutions":[{"id":"https://openalex.org/I4210154236","display_name":"Janssen (Netherlands)","ror":"https://ror.org/04cxegr21","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210154236"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Nina Hertoghs","raw_affiliation_strings":["Janssen Vaccines and Prevention, Leiden, the Netherlands. Electronic address: nhertogh@its.jnj.com"],"raw_orcid":"https://orcid.org/0000-0002-9294-6586","affiliations":[{"raw_affiliation_string":"Janssen Vaccines and Prevention, Leiden, the Netherlands. Electronic address: nhertogh@its.jnj.com","institution_ids":["https://openalex.org/I4210154236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080736729","display_name":"Sanne Roels","orcid":"https://orcid.org/0000-0001-9696-3255","observed_orcids":["https://orcid.org/0000-0001-9696-3255","https://orcid.org/0009-0009-3453-5269"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Sanne Roels","raw_affiliation_strings":["Janssen Research and Development, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Matthias Br\u00fcckner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Matthias Br\u00fcckner","raw_affiliation_strings":["Janssen Research and Development, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034781292","display_name":"JERALD C. SADOFF","orcid":"https://orcid.org/0000-0002-4839-3013","observed_orcids":["https://orcid.org/0000-0002-4839-3013"]},"institutions":[{"id":"https://openalex.org/I4210154236","display_name":"Janssen (Netherlands)","ror":"https://ror.org/04cxegr21","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210154236"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jerald Sadoff","raw_affiliation_strings":["Janssen Vaccines and Prevention, Leiden, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Vaccines and Prevention, Leiden, the Netherlands","institution_ids":["https://openalex.org/I4210154236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008605547","display_name":"Barbara L. Banbury","orcid":"https://orcid.org/0000-0001-7332-7117","observed_orcids":["https://orcid.org/0000-0001-7332-7117"]},"institutions":[{"id":"https://openalex.org/I4210106996","display_name":"Adaptive Biotechnologies (United States)","ror":"https://ror.org/01gbt6a54","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara L. Banbury","raw_affiliation_strings":["Adaptive Biotechnologies Corp, Seattle, WA, USA"],"raw_orcid":"https://orcid.org/0000-0001-7332-7117","affiliations":[{"raw_affiliation_string":"Adaptive Biotechnologies Corp, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210106996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035216019","display_name":"Nicholas K. Akers","orcid":"https://orcid.org/0000-0003-2161-2869","observed_orcids":["https://orcid.org/0000-0003-2161-2869"]},"institutions":[{"id":"https://openalex.org/I4210106996","display_name":"Adaptive Biotechnologies (United States)","ror":"https://ror.org/01gbt6a54","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas K. Akers","raw_affiliation_strings":["Adaptive Biotechnologies Corp, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adaptive Biotechnologies Corp, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210106996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107860161","display_name":"Bryan Howie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106996","display_name":"Adaptive Biotechnologies (United States)","ror":"https://ror.org/01gbt6a54","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bryan Howie","raw_affiliation_strings":["Adaptive Biotechnologies Corp, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adaptive Biotechnologies Corp, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210106996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015970952","display_name":"Harlan S. Robins","orcid":"https://orcid.org/0000-0001-5225-7076","observed_orcids":["https://orcid.org/0000-0001-5225-7076"]},"institutions":[{"id":"https://openalex.org/I4210106996","display_name":"Adaptive Biotechnologies (United States)","ror":"https://ror.org/01gbt6a54","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harlan S. Robins","raw_affiliation_strings":["Adaptive Biotechnologies Corp, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adaptive Biotechnologies Corp, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210106996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078302426","display_name":"Griet A. Van Roey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210154236","display_name":"Janssen (Netherlands)","ror":"https://ror.org/04cxegr21","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210154236"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Griet A. van Roey","raw_affiliation_strings":["Janssen Vaccines and Prevention, Leiden, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Vaccines and Prevention, Leiden, the Netherlands","institution_ids":["https://openalex.org/I4210154236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040466825","display_name":"Jeroen T. B. M. Tolboom","orcid":"https://orcid.org/0000-0001-8512-7382","observed_orcids":["https://orcid.org/0000-0001-8512-7382"]},"institutions":[{"id":"https://openalex.org/I4210154236","display_name":"Janssen (Netherlands)","ror":"https://ror.org/04cxegr21","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210154236"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jeroen T.B.M. Tolboom","raw_affiliation_strings":["Janssen Vaccines and Prevention, Leiden, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Vaccines and Prevention, Leiden, the Netherlands","institution_ids":["https://openalex.org/I4210154236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035783463","display_name":"Veronica V. Rezelj","orcid":"https://orcid.org/0000-0003-1571-8325","observed_orcids":["https://orcid.org/0000-0003-1571-8325"]},"institutions":[{"id":"https://openalex.org/I4210154236","display_name":"Janssen (Netherlands)","ror":"https://ror.org/04cxegr21","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210154236"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Veronica V. Rezelj","raw_affiliation_strings":["Janssen Vaccines and Prevention, Leiden, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Vaccines and Prevention, Leiden, the Netherlands","institution_ids":["https://openalex.org/I4210154236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021703028","display_name":"Jenny Hendriks","orcid":"https://orcid.org/0009-0008-8191-6200","observed_orcids":["https://orcid.org/0009-0008-8191-6200"]},"institutions":[{"id":"https://openalex.org/I4210154236","display_name":"Janssen (Netherlands)","ror":"https://ror.org/04cxegr21","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210154236"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jenny Hendriks","raw_affiliation_strings":["Janssen Vaccines and Prevention, Leiden, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Vaccines and Prevention, Leiden, the Netherlands","institution_ids":["https://openalex.org/I4210154236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014967648","display_name":"Hanneke Schuitemaker","orcid":"https://orcid.org/0000-0001-8563-2266","observed_orcids":["https://orcid.org/0000-0001-8563-2266"]},"institutions":[{"id":"https://openalex.org/I4210154236","display_name":"Janssen (Netherlands)","ror":"https://ror.org/04cxegr21","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210154236"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Hanneke Schuitemaker","raw_affiliation_strings":["Janssen Vaccines and Prevention, Leiden, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Vaccines and Prevention, Leiden, the Netherlands","institution_ids":["https://openalex.org/I4210154236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072872473","display_name":"Daniel J Stieh","orcid":"https://orcid.org/0009-0003-8523-1528","observed_orcids":["https://orcid.org/0009-0003-8523-1528"]},"institutions":[{"id":"https://openalex.org/I4210154236","display_name":"Janssen (Netherlands)","ror":"https://ror.org/04cxegr21","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210154236"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Daniel J. Stieh","raw_affiliation_strings":["Janssen Vaccines and Prevention, Leiden, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Vaccines and Prevention, Leiden, the Netherlands","institution_ids":["https://openalex.org/I4210154236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113844243","display_name":"Mathieu Le Gars","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210154236","display_name":"Janssen (Netherlands)","ror":"https://ror.org/04cxegr21","country_code":"NL","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210154236"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Mathieu Le Gars","raw_affiliation_strings":["Janssen Vaccines and Prevention, Leiden, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Vaccines and Prevention, Leiden, the Netherlands","institution_ids":["https://openalex.org/I4210154236"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5077878781"],"corresponding_institution_ids":["https://openalex.org/I4210154236"],"apc_list":{"value":5780,"currency":"USD","value_usd":5780},"apc_paid":{"value":5780,"currency":"USD","value_usd":5780},"fwci":9.898,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.98880307,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"117","issue":null,"first_page":"105809","last_page":"105809"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.8389999866485596},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9660000205039978},{"id":"https://openalex.org/keywords/vaccine-induced-t-cell-responses","display_name":"vaccine-induced T cell responses","score":0.7889999747276306},{"id":"https://openalex.org/keywords/t-cell-receptor-sequencing","display_name":"T cell receptor sequencing","score":0.8640000224113464},{"id":"https://openalex.org/keywords/severe-covid-19","display_name":"severe COVID-19","score":0.8289999961853027},{"id":"https://openalex.org/keywords/breakthrough-infection","display_name":"breakthrough infection","score":0.8539999723434448},{"id":"https://openalex.org/keywords/spike-specific-t-cells","display_name":"spike-specific T cells","score":0.656000018119812},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.7269999980926514},{"id":"https://openalex.org/keywords/janssen-covid-19-vaccine","display_name":"Janssen COVID-19 vaccine","score":0.8119999766349792},{"id":"https://openalex.org/keywords/cell-mediated-immunity","display_name":"cell-mediated immunity","score":0.5730000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6484217643737793},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.6077570915222168},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5947850346565247},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5844652652740479},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.56496661901474},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.5364945530891418},{"id":"https://openalex.org/C2778190748","wikidata":"https://www.wikidata.org/wiki/Q7907956","display_name":"Vaccine trial","level":3,"score":0.4649459421634674},{"id":"https://openalex.org/C160798450","wikidata":"https://www.wikidata.org/wiki/Q4230870","display_name":"Concordance","level":2,"score":0.4359390437602997},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.43549543619155884},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.4201534390449524},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3601999878883362},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3533434271812439},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32647964358329773},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12442022562026978},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.09069100022315979},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000086663","descriptor_name":"COVID-19 Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000086663","descriptor_name":"COVID-19 Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011948","descriptor_name":"Receptors, Antigen, T-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011948","descriptor_name":"Receptors, Antigen, T-Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D064370","descriptor_name":"Spike Glycoprotein, Coronavirus","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.ebiom.2025.105809","doi":"https://doi.org/10.1016/j.ebiom.2025.105809","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ebiom.2025.105809","pdf_url":"https://www.thelancet.com/action/showPdf?pii=S2352396425002531","source":{"id":"https://openalex.org/S2531685872","display_name":"EBioMedicine","issn_l":"2352-3964","issn":["2352-3964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"eBioMedicine","raw_type":"journal-article"},{"id":"pmid:40517603","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40517603","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EBioMedicine","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:pubmedcentral.nih.gov:12278623","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12278623/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"eBioMedicine","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:813caf959c59472bb733cc0a47ad1d89","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/813caf959c59472bb733cc0a47ad1d89","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"EBioMedicine, Vol 117, Iss , Pp 105809- (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.ebiom.2025.105809","doi":"https://doi.org/10.1016/j.ebiom.2025.105809","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ebiom.2025.105809","pdf_url":"https://www.thelancet.com/action/showPdf?pii=S2352396425002531","source":{"id":"https://openalex.org/S2531685872","display_name":"EBioMedicine","issn_l":"2352-3964","issn":["2352-3964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"eBioMedicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7419628694","display_name":null,"funder_award_id":"HHSO100201700018C","funder_id":"https://openalex.org/F4320333299","funder_display_name":"Biomedical Advanced Research and Development Authority"}],"funders":[{"id":"https://openalex.org/F4320333299","display_name":"Biomedical Advanced Research and Development Authority","ror":"https://ror.org/029y69023"},{"id":"https://openalex.org/F4320337804","display_name":"Johnson and Johnson Pharmaceutical Research and Development","ror":"https://ror.org/05wae1a98"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4411299435.pdf","grobid_xml":"https://content.openalex.org/works/W4411299435.grobid-xml"},"referenced_works_count":54,"referenced_works":["https://openalex.org/W1822028895","https://openalex.org/W1998518732","https://openalex.org/W2028627357","https://openalex.org/W2043071551","https://openalex.org/W2074640340","https://openalex.org/W2131682431","https://openalex.org/W2166221102","https://openalex.org/W2946450286","https://openalex.org/W3084879098","https://openalex.org/W3092050672","https://openalex.org/W3108193091","https://openalex.org/W3111281430","https://openalex.org/W3119345685","https://openalex.org/W3119858919","https://openalex.org/W3121177038","https://openalex.org/W3123967880","https://openalex.org/W3137469790","https://openalex.org/W3153508314","https://openalex.org/W3162400064","https://openalex.org/W3163785571","https://openalex.org/W3164547793","https://openalex.org/W3173512675","https://openalex.org/W3174017401","https://openalex.org/W3175436048","https://openalex.org/W3177895433","https://openalex.org/W3184172540","https://openalex.org/W3217661335","https://openalex.org/W4205145778","https://openalex.org/W4207047906","https://openalex.org/W4211043735","https://openalex.org/W4220718129","https://openalex.org/W4220886379","https://openalex.org/W4224232618","https://openalex.org/W4225011156","https://openalex.org/W4226023532","https://openalex.org/W4226090490","https://openalex.org/W4226096713","https://openalex.org/W4229056490","https://openalex.org/W4281621690","https://openalex.org/W4282933024","https://openalex.org/W4284969220","https://openalex.org/W4285804275","https://openalex.org/W4308774038","https://openalex.org/W4311448444","https://openalex.org/W4321782896","https://openalex.org/W4323664245","https://openalex.org/W4323921279","https://openalex.org/W4360871696","https://openalex.org/W4404278305","https://openalex.org/W4406128352","https://openalex.org/W6781300227","https://openalex.org/W6792488599","https://openalex.org/W6795576515","https://openalex.org/W6797853665"],"related_works":["https://openalex.org/W4322723387","https://openalex.org/W4225011156","https://openalex.org/W4383499742","https://openalex.org/W4404730814","https://openalex.org/W4406923260","https://openalex.org/W4308432062","https://openalex.org/W4210792795","https://openalex.org/W4226096713","https://openalex.org/W4400512773","https://openalex.org/W3213230441"],"abstract_inverted_index":{"BACKGROUND:":[0],"While":[1],"vaccine-induced":[2,18],"SARS-CoV-2":[3,102,108],"antibodies":[4],"provide":[5],"partial":[6],"protection":[7,40,202,245],"against":[8,41,203],"COVID-19,":[9,168,224],"a":[10,117,146,236],"significant":[11],"question":[12],"remains":[13],"regarding":[14],"the":[15,35,64,163],"role":[16],"of":[17,26,34,73,89,124,165,222,229],"T":[19,45,110,141,157,197,213,241],"cells":[20],"in":[21,63,192],"combating":[22],"COVID-19.":[23,43,205,232,248],"The":[24,70,261],"purpose":[25],"this":[27],"study":[28],"is":[29],"to":[30,39,100,106,128,194,201],"investigate":[31],"whether":[32],"signatures":[33],"T-cell":[36],"response":[37,126],"contribute":[38,200],"(severe)":[42],"METHODS:":[44],"cell":[46,111,142,158,198,214,242],"receptor":[47],"(TCR)":[48],"sequencing":[49,153],"was":[50,98,173,252,268],"conducted":[51],"using":[52],"pre-vaccination":[53],"and":[54,85,94,103,116,137,151,187,244,275],"29":[55],"days":[56],"post-vaccination":[57],"PAXgene":[58],"samples":[59,262],"from":[60,246,265],"396":[61],"participants":[62],"phase":[65],"3":[66],"efficacy":[67],"trial,":[68],"ENSEMBLE.":[69],"dataset":[71],"consists":[72],"198":[74],"individuals":[75],"who":[76],"developed":[77],"breakthrough":[78],"COVID-19":[79,178],"infections,":[80],"including":[81,183],"23":[82],"severe":[83,167,204,223,247],"cases,":[84],"an":[86],"equal":[87],"number":[88],"matched":[90],"control":[91],"subjects.":[92],"Immunosequencing":[93],"subsequent":[95],"computational":[96],"analysis":[97,182],"performed":[99],"identify":[101],"Spike-specific":[104],"TCRs":[105],"quantify":[107],"specific":[109],"breadth,":[112],"depth,":[113],"clonal":[114],"expansion,":[115],"model":[118],"test":[119],"score":[120],"that":[121,210],"describes":[122],"magnitude":[123],"cellular":[125],"compared":[127],"pre-pandemic":[129],"controls.":[130],"FINDINGS:":[131],"Preliminary":[132],"analyses":[133],"demonstrated":[134],"high":[135],"concordance":[136],"correlation":[138,238],"between":[139,239],"functional":[140],"responses":[143,159,199,215,243],"measured":[144],"by":[145,255,271],"standard":[147],"intracellular":[148],"cytokine":[149],"staining":[150],"TCR":[152,188],"metrics.":[154],"Furthermore,":[155],"vaccine-elicited":[156,212,240],"correlated":[160,218],"inversely":[161],"with":[162,175,219,227],"risk":[164,221,228],"developing":[166],"while":[169],"no":[170],"strong":[171],"relation":[172],"observed":[174],"overall":[176],"symptomatic":[177,231],"risk.":[179],"A":[180],"multivariable":[181],"neutralizing":[184],"antibody":[185],"data":[186],"scores":[189],"indicated":[190],"that,":[191],"addition":[193],"humoural":[195],"responses,":[196],"INTERPRETATION:":[206],"Our":[207],"findings":[208],"show":[209],"higher":[211],"are":[216],"significantly":[217],"decreased":[220],"but":[225],"not":[226],"any":[230],"These":[233],"results":[234],"represent":[235],"direct":[237],"FUNDING:":[249],"This":[250],"work":[251],"fully":[253],"funded":[254,270],"Janssen":[256],"Vaccines":[257],"&":[258],"Prevention":[259],"B.V.":[260],"were":[263],"sourced":[264],"ENSEMBLE,":[266],"which":[267],"partly":[269],"Biomedical":[272],"Advanced":[273],"Research":[274],"Development":[276],"Authority":[277],"(BARDA),":[278],"under":[279],"other":[280],"transaction":[281],"agreement":[282],"HHSO100201700018C.":[283]},"counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-10-10T00:00:00"}